TCMD insider trading
Open-market stock trades by Tactile Systems (TCMD) executives and directors: who bought or sold, how many shares, at what price and when.
TCMD insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Dodd Sheri Louise | Chief Executive Officer | Sell | 10,978 | $29.44 | $323.24K |
| May 11, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sell | 4,631 | $24.49 | $113.40K |
| Feb 24, 2026 | Dodd Sheri Louise | Chief Executive Officer | Sell | 10,993 | $28.94 | $318.14K |
| Feb 24, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sell | 7,701 | $28.94 | $222.88K |
| Feb 24, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 6,246 | $28.94 | $180.76K |
| Feb 23, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sell | 5,322 | $28.28 | $150.52K |
| Feb 23, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sell | 196 | $28.69 | $5.62K |
| Feb 23, 2026 | Dodd Sheri Louise | Chief Executive Officer | Sell | 14,703 | $28.28 | $415.84K |
| Feb 23, 2026 | Dodd Sheri Louise | Chief Executive Officer | Sell | 537 | $28.69 | $15.41K |
| Feb 23, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 4,279 | $28.28 | $121.02K |
| Feb 23, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 160 | $28.69 | $4.59K |
| Jan 2, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 5,139 | $28.85 | $148.26K |
| Aug 8, 2025 | Dodd Sheri Louise | Chief Executive Officer | Sell | 7,762 | $12.36 | $95.91K |
| May 12, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 2,921 | $9.94 | $29.04K |
| May 8, 2025 | Dodd Sheri Louise | Chief Executive Officer | Sell | 3,149 | $9.83 | $30.95K |
| May 8, 2025 | BURKE WILLIAM W | director | Sell | 3,300 | $9.67 | $31.91K |
| Feb 25, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 2,066 | $14.51 | $29.98K |
| Feb 25, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 6,468 | $14.40 | $93.16K |
| Feb 25, 2025 | REUVERS DANIEL L. | director | Sell | 28,338 | $14.18 | $401.85K |
| Feb 24, 2025 | REUVERS DANIEL L. | director | Sell | 10,938 | $14.55 | $159.15K |
| Feb 24, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 4,830 | $14.65 | $70.75K |
| Feb 24, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 3,778 | $14.70 | $55.54K |
| Aug 12, 2024 | Ferstler Sherri Lee | Senior VP, Sales | Sell | 1,550 | $13.07 | $20.26K |
| May 16, 2024 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 3,041 | $13.68 | $41.59K |
| May 8, 2024 | BURKE WILLIAM W | director | Sell | 2,500 | $14.06 | $35.15K |
| May 6, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 815 | $14.37 | $11.71K |
| Feb 27, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 1,091 | $15.58 | $17.00K |
| Feb 29, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 243 | $15.25 | $3.71K |
| Feb 27, 2024 | REUVERS DANIEL L. | President and CEO | Sell | 4,689 | $15.60 | $73.15K |
| Feb 29, 2024 | REUVERS DANIEL L. | President and CEO | Sell | 1,396 | $15.25 | $21.29K |
| Feb 26, 2024 | REUVERS DANIEL L. | President and CEO | Sell | 6,239 | $15.81 | $98.64K |
| Feb 23, 2024 | REUVERS DANIEL L. | President and CEO | Sell | 5,378 | $14.85 | $79.85K |
| Feb 26, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 2,015 | $15.90 | $32.05K |
| Feb 23, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 2,249 | $14.80 | $33.28K |
| Aug 7, 2023 | REUVERS DANIEL L. | President and CEO | Sell | 1,062 | $20.53 | $21.81K |
| May 12, 2023 | BURKE WILLIAM W | director | Sell | 4,400 | $21.86 | $96.18K |
- TCMD insiders bought $0.00 and sold $3.60M in open-market trades over their last 36 filings.
Updated 2026-11-05 12:48 UTC